DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

D. W. Wu, M. C. Lee, J. Wang, C. Y. Chen, Y. W. Cheng, H. Lee

Research output: Contribution to journalArticlepeer-review

69 Citations (Scopus)

Fingerprint

Dive into the research topics of 'DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences